Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
16.72
-0.33 (-1.94%)
At close: Jun 26, 2026, 4:00 PM EDT
16.77
+0.05 (0.30%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Ascentage Pharma Group International Employees
Ascentage Pharma Group International had 767 employees as of December 31, 2025. The number of employees increased by 200 or 35.27% compared to the previous year.
Employees
767
Change
200
Growth
35.27%
Revenue / Employee
$107,018
Profits / Employee
-$231,657
Market Cap
1.43B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 767 | 200 | 35.27% |
| Jun 30, 2025 | 605 | - | - |
| Dec 31, 2024 | 567 | -16 | -2.74% |
| Dec 31, 2023 | 583 | 3 | 0.52% |
| Dec 31, 2022 | 580 | -33 | -5.38% |
| Dec 31, 2021 | 613 | 180 | 41.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Immunocore Holdings | 524 |
| Ardelyx | 489 |
| Capricor Therapeutics | 231 |
| MapLight Therapeutics | 133 |
| Inhibrx Biosciences | 110 |
| Savara | 70 |
| Jade Biosciences | 55 |
AAPG News
- 13 days ago - Ascentage Pharma assumed with an Outperform at Oppenheimer - TheFly
- 14 days ago - Ascentage Pharma announces clinical updates from EHA2026 - TheFly
- 14 days ago - Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress - GlobeNewsWire
- 18 days ago - Ascentage Pharma initiated with a Buy at B. Riley - TheFly
- 25 days ago - Ascentage Pharma Group International Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Ascentage Pharma presents data on olverembatinib - TheFly
- 4 weeks ago - Ascentage Pharma presents data from Phase 1b study of olverembatinib - TheFly
- 4 weeks ago - Ascentage Pharma presents first dataset of alrizomadlin - TheFly